Literature DB >> 36121544

Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point.

Bo Xie1, Jiayi Sun2, Xiuzu Song3.   

Abstract

Alopecia areata (AA) is characterized by common non-scarring alopecia due to autoimmune disorders. To date, the specific pathogenesis underlying AA remains unknown. Thus, AA treatment in the dermatological clinic is still a challenge. Numerous clinical observations and experimental studies have established that melanocytes may be the trigger point that causes hair follicles to be attacked by the immune system. A possible mechanism is that the impaired melanocytes, under oxidative stress, cannot be repaired in time and causes apoptosis. Melanocyte-associated autoantigens are released and presented, inducing CD8+ T cell attacks. Thereafter, amplification of the immune responses further spreads to the entire hair follicle (HF). The immune privilege of HF subsequently collapses, leading to AA. Herein, we present a narrative review on the roles of melanocytes in AA pathogenesis, aiming to provide a better understanding of this disease from the melanocyte's perspective.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alopecia areata; Autoimmunity; Hair follicle; Melanocyte; Trigger point

Year:  2022        PMID: 36121544     DOI: 10.1007/s12016-022-08954-w

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  126 in total

1.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

Authors:  Taisuke Ito; Natsuho Ito; Albrecht Bettermann; Yoshiki Tokura; Masahiro Takigawa; Ralf Paus
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

Review 2.  Alopecia areata.

Authors:  Amos Gilhar; Amos Etzioni; Ralf Paus
Journal:  N Engl J Med       Date:  2012-04-19       Impact factor: 91.245

3.  Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.

Authors:  Harrison H Lee; Eran Gwillim; Kevin R Patel; Tammy Hua; Supriya Rastogi; Erin Ibler; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2019-08-19       Impact factor: 11.527

Review 4.  The role of alpha-melanocyte-stimulating hormone in cutaneous biology.

Authors:  T A Luger; T Scholzen; S Grabbe
Journal:  J Investig Dermatol Symp Proc       Date:  1997-08

Review 5.  Alopecia areata: An appraisal of new treatment approaches and overview of current therapies.

Authors:  Lauren C Strazzulla; Eddy Hsi Chun Wang; Lorena Avila; Kristen Lo Sicco; Nooshin Brinster; Angela M Christiano; Jerry Shapiro
Journal:  J Am Acad Dermatol       Date:  2018-01       Impact factor: 11.527

Review 6.  Alopecia areata: A multifactorial autoimmune condition.

Authors:  Teontor Simakou; John P Butcher; Stuart Reid; Fiona L Henriquez
Journal:  J Autoimmun       Date:  2018-12-15       Impact factor: 7.094

Review 7.  Alopecia areata.

Authors:  C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal:  Nat Rev Dis Primers       Date:  2017-03-16       Impact factor: 52.329

8.  Evidence that the bulge region is a site of relative immune privilege in human hair follicles.

Authors:  K C Meyer; J E Klatte; H V Dinh; M J Harries; K Reithmayer; W Meyer; R Sinclair; R Paus
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

9.  The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care.

Authors:  Abby E Macbeth; Susan Holmes; Matthew Harries; Wing Sin Chiu; Christos Tziotzios; Simon de Lusignan; Andrew G Messenger; Andrew R Thompson
Journal:  Br J Dermatol       Date:  2022-05-11       Impact factor: 11.113

10.  Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.

Authors:  Marta Bertolini; Federica Zilio; Alfredo Rossi; Patrick Kleditzsch; Vladimir E Emelianov; Amos Gilhar; Aviad Keren; Katja C Meyer; Eddy Wang; Wolfgang Funk; Kevin McElwee; Ralf Paus
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.